Physician

Robert E Parnes, MD

According to 2025 Medicare claims, Robert Parnes, MD (NPI: 1407824360) practices ophthalmology in the Hagerstown-Martinsburg, MD-WV market, with the plurality of this provider's patient population coming from Washington, MD. This provider's primary affiliated billing organization is ROBERT E. PARNES, M.D., LLC (NPI: 1205857349; TIN: 204841431) and primary practice location at 21740-6597.

Parnes' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,152 traditional Medicare patients, billed 84,401 HCPCS/CPT codes, and received $4,245,784 in Medicare payments. The top billing code was 92004 (New patient complete exam of visual system). Part D data shows 523 prescription claims across 171 beneficiaries totaling $37,615 in drug costs, led by Prolensa (Bromfenac Sodium). Open Payments data shows 6 records totaling $141,042. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $2,042,650 to $4,245,784. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.1M$4.2M2015 Medicare payment: $2,042,650 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,198,987 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,018,094 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,630,962 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,601,641 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,705,707 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,119,992 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,972,199 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $3,390,961 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $4,245,784 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,14710,567$2,042,650
20161,13310,891$2,198,987
20171,18610,045$2,018,094
20181,29312,789$2,630,962
20191,29512,403$2,601,641
20201,24212,469$2,705,707
20211,22212,538$3,119,992
20221,18313,761$2,972,199
20231,14763,624$3,390,961
20241,15284,401$4,245,784

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$26K$51K2015 Drug cost: $33,443 (USD; Tot_Drug_Cst)2016 Drug cost: $28,280 (USD; Tot_Drug_Cst)2017 Drug cost: $25,987 (USD; Tot_Drug_Cst)2018 Drug cost: $31,701 (USD; Tot_Drug_Cst)2019 Drug cost: $37,021 (USD; Tot_Drug_Cst)2020 Drug cost: $35,604 (USD; Tot_Drug_Cst)2021 Drug cost: $34,796 (USD; Tot_Drug_Cst)2022 Drug cost: $29,007 (USD; Tot_Drug_Cst)2023 Drug cost: $51,116 (USD; Tot_Drug_Cst)2024 Drug cost: $37,615 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201592367$33,443
201688305$28,280
201782252$25,987
2018100351$31,701
2019106454$37,021
2020111432$35,604
2021116396$34,796
2022125434$29,007
2023137532$51,116
2024171523$37,615

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92004New patient complete exam of visual system237237$114
92014Established patient complete exam of visual system1,0272,779$96
67028Injection of drug into eye3332,162$92
92134Imaging of retina1,0462,857$32
J2777Injection, faricimab-svoa, 0.1 mg24666,361$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ProlensaBromfenac Sodium29292$9,880
Bromfenac SodiumBromfenac Sodium37834$8,023
Prednisolone AcetatePrednisolone Acetate1223,339$4,301
Brimonidine TartrateBrimonidine Tartrate12711$2,623
MoxifloxacinMoxifloxacin Hcl901,226$1,836

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.4$110Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.1$140,932EyePoint Pharmaceuticals US, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.1$30,097US Retina LLC

FAQ

What Medicare data is available for Robert E. Parnes, MD?

Tedicare shows public-source Medicare data for Robert E. Parnes, MD (NPI 1407824360), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Robert E. Parnes, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Robert E. Parnes, MD?

Robert E. Parnes, MD is linked to ROBERT E. PARNES, M.D., LLC (billing NPI 1205857349) in the available physician profile data.

Does Robert E. Parnes, MD have Open Payments data?

Robert E. Parnes, MD has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.